Clinical Trials
8 trialsNCT06915025 2026-06-02
OVATION-3
Imunon
Phase 3 Recruiting
NCT05335993 2026-04-03
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
CanariaBio Inc.
Phase 2 Active not recruiting
NCT06086665 2026-02-04
REFIRM
Asan Medical Center
Completed
NCT05385068 2022-05-23
t
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05187208 2022-01-26
POLO
Seoul National University Hospital
Phase 4 Unknown
NCT04546373 2021-08-05
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario
Completed
NCT04986371 2021-08-02
RENI-1
ChineseAMS
Unknown
NCT04556071 2020-11-10
AVANIRA3
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown